Carisbamate: all 21 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsRecruitingNCT05219617Phase 3
- Carisbamate as a Potential Treatment for Alcohol DependenceCompletedNCT02435381Phase 1/2Results posted
- Bioavailability and Food Effect Study of 3 Types of CarisbamateCompletedNCT04520360Phase 1
- Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut SyndromeCompletedNCT04062981Phase 1
- Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut SyndromeCompletedNCT03731715Phase 1
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.CompletedNCT00991757Phase 3
- An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in DiabeticsCompletedNCT00870454Phase 2
- An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset SeizuresCompletedNCT00744731Phase 3
- A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.CompletedNCT00740623Phase 3
- Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset SeizuresCompletedNCT00697918Phase 3
- Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset SeizuresTerminatedNCT00697762Phase 3
- Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.TerminatedNCT00563459Phase 3
- A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential TremorCompletedNCT00524056Phase 2
- Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).CompletedNCT00501202Phase 2
- An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).CompletedNCT00492323Phase 2
- A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.CompletedNCT00433667Phase 3
- A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.CompletedNCT00425282Phase 3
- Safety and Efficacy of 333369 in the Treatment of Partial EpilepsyCompletedNCT00228969Phase 2
- An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With EpilepsyCompletedNCT00210652Phase 2
- An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With EpilepsyCompletedNCT00210522Phase 2
- A Study of the Efficacy of RWJ-333369 in the Prevention of MigraineCompletedNCT00109083Phase 2